U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07601802) titled 'Acute Risk Monitoring for Oncology Therapy Regimen' on May 15.
Brief Summary: Patients undergoing outpatient infusion systemic therapy for cancer are at risk for potentially preventable, unplanned acute care in the form of emergency department (ED) visits and hospitalizations. These events impact patient outcomes, treatment decisions, and healthcare costs. To address this need, the Centers for Medicare & Medicaid Services developed the chemotherapy measure (OP-35). Recent randomized controlled studies indicate that electronic health record (EHR)-based machine learning (ML) approaches accurately direct supportive care to reduce acute ...